9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma

Estimated Enrollment: 60

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Active, not recruiting

Study Results: No Results Available

Outcome Measures: Number of subjects reporting adverse events,  Induction of immune response to mesothelin by enzyme-linked immunosorbent spot (ELISPOT) assay,  Objective tumor response, Time to progression

Interventions: Immunotherapy plus chemotherapy, Immunotherapy with cyclophosphamide plus chemotherapy

Phase:

Study Type: Interventional

Study Design: Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: None (Open Label),Primary Purpose: Treatment

Primary Completion Date: June 2019

Completion Date: June 2019

Last  Posted Date: January 9, 2019

Location: University of California at San Francisco, San Francisco, California, United States

Website Link: https://ClinicalTrials.gov/show/NCT01675765

Was this article helpful?
Dislike 0